Oruka Therapeutics, Inc.
ORKA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$84 | – | -$10 | -$19 |
| Dep. & Amort. | $0 | – | $0 | $0 |
| Deferred Tax | $0 | – | $0 | $0 |
| Stock-Based Comp. | $0 | – | $0 | $0 |
| Change in WC | $12 | – | -$2 | -$0 |
| Other Non-Cash | $14 | – | $1 | $0 |
| Operating Cash Flow | -$58 | – | -$11 | -$19 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | – | -$0 | -$0 |
| Net Acquisitions | $0 | – | $0 | $0 |
| Inv. Purchases | -$330 | – | $0 | $0 |
| Inv. Sales/Matur. | $0 | – | $0 | $0 |
| Other Inv. Act. | $0 | – | $0 | $0 |
| Investing Cash Flow | -$330 | – | -$0 | -$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | – | $0 | $0 |
| Stock Issued | $450 | – | $0 | $23 |
| Stock Repurch. | $0 | – | $0 | $0 |
| Dividends Paid | $0 | – | $0 | $0 |
| Other Fin. Act. | $0 | – | $0 | $0 |
| Financing Cash Flow | $450 | – | $0 | $23 |
| Forex Effect | -$37 | – | $0 | $0 |
| Net Chg. in Cash | $24 | – | -$11 | $4 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $37 | – | $53 | $49 |
| End Cash | $62 | – | $42 | $53 |
| Free Cash Flow | -$58 | – | -$11 | -$19 |